Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Neoplasm of the central nervous system and Prostate cancer.
Biomarker and diagnostic research for prostate cancer/brain cancer susceptibility has been reported in the published literature.
No clinical trials have been registered for prostate cancer/brain cancer susceptibility.
21 publications have been identified in PubMed for prostate cancer/brain cancer susceptibility. Research spans Epidemiology / Natural History (43%), Basic Science / Preclinical (33%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 9 | 43% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 8:17 PM UTC
Online Mendelian Inheritance in Man
Laboratory research |
7 |
33% |
Research summaries | 3 | 14% |
Testing and diagnosis research | 2 | 10% |
He X (2026). [PMID: 41190396](https://pubmed.ncbi.nlm.nih.gov/41190396/). *Clinical nephrology*. [Epidemiology / Natural History]
Debnath D (2026). [PMID: 41898760](https://pubmed.ncbi.nlm.nih.gov/41898760/). *International journal of molecular sciences*. [Epidemiology / Natural History]
Li Q (2026). [PMID: 42090444](https://pubmed.ncbi.nlm.nih.gov/42090444/). *PLoS Genet*. [Basic Science / Preclinical]
Goldstein AM (2026). [PMID: 42201696](https://pubmed.ncbi.nlm.nih.gov/42201696/). *JAMA Dermatol*. [Epidemiology / Natural History]
Fahey JW (2026). [PMID: 42201192](https://pubmed.ncbi.nlm.nih.gov/42201192/). *Medicines (Basel)*. [Review / Meta-Analysis]
Liu P (2025). [PMID: 40816316](https://pubmed.ncbi.nlm.nih.gov/40816316/). *Physics in medicine and biology*. [Diagnostic / Biomarker]
Yang F (2025). [PMID: 40955046](https://pubmed.ncbi.nlm.nih.gov/40955046/). *CNS neuroscience & therapeutics*. [Basic Science / Preclinical]
Yu J (2025). [PMID: 40166329](https://pubmed.ncbi.nlm.nih.gov/40166329/). *bioRxiv : the preprint server for biology*. [Epidemiology / Natural History]
Yu J (2025). [PMID: 40788171](https://pubmed.ncbi.nlm.nih.gov/40788171/). *Clinical cancer research : an official journal of the American Association for Cancer Research*. [Basic Science / Preclinical]
Lee J (2025). [PMID: 40945217](https://pubmed.ncbi.nlm.nih.gov/40945217/). *Computers in biology and medicine*. [Diagnostic / Biomarker]
AI-curated news mentioning prostate cancer/brain cancer susceptibility
Updated Jan 29, 2026
A new observational study sponsored by the National Cancer Institute aims to evaluate treatment responses in patients with advanced central nervous system tumors, including various types of gliomas. The study is currently not yet recruiting participants.